ABCC2 and neutropenia: At the first cycle of treatment, ABCC2 c.3972C > T was significantly associated with all grades neutropenia [grade 1–4 neutropenia; odds ratio (OR) 3, 95% confidence intervals (CI) 1.3–7; P < 0.012].